AUS
NZ
UK
CA
USA
IND
Healthcare
Why HeraMED Is On The Rise Today? – A Quick Look
January 21, 2019 11:40 PM AEDT| By Team Kalkine MediaTechnology startup, HeraMED Limited (ASX: HMD) debut on ASX in December 2018 after completing its over-subscribed $6 million Initial Public Offering (IPO). The company manufactures and supplies its innovative product HeraBEAT which is a smartphone-ba...
Creso Signs Three-Year Supply Agreement With TerrAscend Canada For Premium Cannabis Sales
January 21, 2019 06:37 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) has signed a three-year supply agreement with TerrAscend Canada, a wholly-owned subsidiary of TerrAscend Corp., (CSE: TER; OTCQX: TRSSF) (?TerrAscend?) to deliver its premium cannabis product to help meet the substanti...
Healthscope Provided Update On Brookfield’s Acquisition Proposal
January 21, 2019 01:47 PM AEDT| By Team Kalkine MediaAustralia?s leading private healthcare provider, Healthscope Limited (ASX: HSO) has provided an update on the previously announced proposal from Brookfield Capital Partners Ltd. The proposal is regarding the acquisition of 100% shares of Healthscope...
Do You Know Why Biotron Stock Is Surging High?
January 18, 2019 09:25 PM AEDT| By Team Kalkine MediaHealth Care company Biotron Limited (ASX: BIT) today announced the quarterly cash flow report for the period ended 31 December 2018. Cash flows from operating activities accounted for an inflow of $380,000 during 2Q FY19. But for the entire year to d...
Antisense’s Stocks Surged On ASX After The Announcement Of Phase 2 Clinical Trial for DMD
January 18, 2019 05:00 PM AEDT| By Team Kalkine MediaAntisense Therapeutics Limited (ASX: ANP) is a biopharmaceutical company which is primarily into the discovery and development of drugs. The company has an objective to create, develop and commercialize novel antisense pharmaceuticals patients with d...
MGC Pharmaceuticals’ Shares Uplifted On ASX After Publishing Its Quarterly Activity Report
January 18, 2019 03:53 PM AEDT| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC) wants to be an innovator in the global Phytocannabinoid-based medicine. It has technical and professional experience of several years. The company wants to create and supply high-quality Cannabinoid based pharmaceut...
Genera Biosystems Obtains Decent R&D Tax Rebate ($438,087) From ATO
January 17, 2019 08:00 PM AEDT| By Team Kalkine MediaOn 17 January 2019, the Board of Genera Biosystems Limited (ASX: GBI) announced that the company has been granted $438,087 R&D Tax Incentive rebate by Australian Taxation Authority for 2018 financial year, which includes an amount payable that wa...
Pharmaxis’ Shares Uplifted On ASX As Its Inhibitor Program Is Ready To Enter Phase 2 Clinical Studies
January 17, 2019 07:18 PM AEDT| By Team Kalkine MediaThe Pharmaceutical research company, Pharmaxis Limited (ASX: PXS) made an announcement on 17 January 2019 stating that it has received reports on all of the 13?week toxicity studies conducted for each of its two Lysyl Oxidase Like 2 (LOXL2) inhibitor...
Anteo Diagnostics Signs Collaboration with Sona Nanotech – What Investors Need to Know
January 17, 2019 07:07 PM AEDT| By Team Kalkine MediaAnteo Diagnostics Limited (ASX: ADO) is a nanotechnology company. It is into development and commercializing of products in the life sciences research, diagnostics, energy and in the market for medical devices. Anteo Technologies Pty Ltd is a fully-o...
Why These Two Healthcare Stocks Spiked Up In Last 5 Trading Days – HMD And KZA?
January 17, 2019 04:07 PM AEDT| By Team Kalkine MediaHeraMED Limited?(ASX: HMD) HeraMED Limited?(ASX: HMD) is a technology-driven healthcare company which provides innovative pregnancy monitoring solutions to its customers. In December 2018, the company was listed on ASX after the successful completio...
Cannabis License From The Health Department May Enhance Impression Healthcare’s Operations
January 16, 2019 06:17 PM AEDT| By Team Kalkine MediaImpression Healthcare Limited (ASX: IHL) is into the business of providing high quality, personalized dental health care products to its consumers. It is a nation-wide service provider to individuals, schools and sports clubs. It is capable of large-...
The Share Price Of RHT Zoomed Up By 10% After The Execution Of The Distribution Agreement
January 15, 2019 11:15 PM AEDT| By Team Kalkine MediaResonance Health Limited (ASX: RHT), a medical device software company from the health care equipment & services sector announced that it entered into a distribution agreement with EnvoyAI Inc, a US Delaware Corporation for the distribution of RH...
Prescient Therapeutics Announces The Receipts of R&D Tax Rebate
January 15, 2019 06:38 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Prescient Therapeutics Limited (ASX: PTX) announced that the company had received Tax Incentive rebate on research and development for the financial year 2017-2018, amounting to $939,423. The R&D Tax Incentive is an Australian...
CardieX Limited’s Stock Zooms Up On Executing Co-Marketing Agreement With US Health Insurer
January 15, 2019 04:06 PM AEDT| By Team Kalkine MediaCardieX Limited (ASX: CDX) announced the execution of Co-marketing agreement between inHealth Medical Services Inc and Anthem Inc to jointly promote the services of inHealth across Anthem?s healthcare and health insurance networks in the United State...
Kazia Therapeutics Receives $2.2 Million R&D Cash Rebate From ATO
January 15, 2019 03:23 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) announced that it has received approximately $2.2 million cash rebate from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30...
Clinuvel Update: Regulatory Timeline, Expansion Plans For SCENESSE® (afamelanotide 16mg)
January 15, 2019 02:15 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Clinuvel Pharmaceuticals Limited (ASX: CUV) announced major timelines for the FDA approvals on the overall benefit-risk assessment of SCENESSE? (afamelanotide 16mg), company?s flagship photoprotective drug for the prevention of ph...
Healthcare Stocks Under Focus- HMD And MSB
January 14, 2019 11:21 PM AEDT| By Team Kalkine MediaThe below mention stocks are part of Australia?s biggest industry, i.e., Healthcare Industry. In the recent past, these healthcare stocks have made significant progress in their strategic objectives. Let?s take a closer look at these stocks- HeraMED...
Noxopharm’s Shares Uplifted 15% On ASX After Providing Update On Its LuPIN-1 Study
January 14, 2019 05:20 PM AEDT| By Team Kalkine MediaClinical-stage Australian drug development company, Noxopharm Limited (ASX: NOX) has released an interview with Associate Professor Louise Emmett who is the co-Principal Investigator of the LuPIN-1 Study which is being conducted at St Vincent?s Hospi...
Capitol Health Announced The Acquisition Of 4 Clinics In Metropolitan Melbourne From Uniradiology
January 14, 2019 02:12 PM AEDT| By Team Kalkine MediaOn 14 January 2019, Australia?s leading provider of diagnostic imaging and related services, Capitol Health Limited (ASX: CAJ) announced the acquisition of a network of 4 clinics in metropolitan Melbourne from Uniradiology. Despite this news, the sha...
2 Small-Cap Healthcare Stocks – BIT And BNO
January 11, 2019 11:11 PM AEDT| By Team Kalkine MediaHealthcare industry is one of the biggest industries in Australia and investors should always keep a close eye on the stocks that are part of this Industry. The below mentioned two Healthcare Stocks have made some key strategic progress in the recent...
Advertise your brand on Kalkine Media